Citation Impact
Citing Papers
Ultrasound-guided infraclavicular brachial plexus block enhances postoperative blood flow in arteriovenous fistulas
2011
Transplantation ofex vivoexpanded endothelial progenitor cells for therapeutic neovascularization
2000 Standout
Microbiota in health and diseases
2022 Standout
AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms
2017
Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression
2017 Standout
Oxidative stress, aging, and diseases
2018 Standout
Guidelines on Urolithiasis<footref rid="foot01"><sup>1</sup></footref>
2001 Standout
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
Endocan — the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular disease
2015
Oral Phosphate Binders in Patients with Kidney Failure
2010
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism
2005 Standout
Increase in Oxidative Stress but Not in Antioxidant Capacity with Advancing Stages of Chronic Kidney Disease
2007
Cytokine Dysregulation in Chronic Kidney Disease: How Can We Treat It?
2008
Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta‐analysis and systemic review
2011
Dysfunctional high-density lipoproteins in children with chronic kidney disease
2014
Dietary Polyphenols and the Prevention of Diseases
2005 Standout
Inflammation in End-Stage Renal Disease-What Have We Learned in 10 Years?
2010
Endocan: A novel inflammatory indicator in cardiovascular disease?
2015 Standout
Indoxyl Sulfate–Induced Endothelial Dysfunction in Patients with Chronic Kidney Disease via an Induction of Oxidative Stress
2010
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
2008 Standout
Redox-related biomarkers in human cardiovascular disease - classical footprints and beyond
2021
Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol
2016
Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: A meta-analysis of randomised controlled trials
2011
Mechanism of endothelial dysfunction in chronic kidney disease
2010
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Clinical and research markers of oxidative stress in chronic kidney disease
2013
Chronic kidney disease alters intestinal microbial flora
2012 Standout
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Chronic kidney disease
2011 Standout
Uric Acid Lowering to Prevent Kidney Function Loss in Diabetes: The Preventing Early Renal Function Loss (PERL) Allopurinol Study
2013
Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease
2019
Mechanical and chemical recycling of solid plastic waste
2017 Standout
Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis
2013
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study
2010
Flavonoids: a review of probable mechanisms of action and potential applications
2001 Standout
Oxidative stress in autosomal dominant polycystic kidney disease: player and/or early predictor for disease progression?
2018
Effect of brachial plexus block-driven vascular access planning on primary distal arteriovenous fistula recruitment and outcomes
2015
eNOS Knockout Mice with Advanced Diabetic Nephropathy Have Less Benefit from Renin-Angiotensin Blockade than from Aldosterone Receptor Antagonists
2009
Acute kidney injury
2021 Standout
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
2005 StandoutNature
The emerging pleiotrophic role of adipokines in the uremic phenotype
2009
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels
2009
Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis
2011 Standout
The Central Role of Endothelial Dysfunction in Cardiorenal Syndrome
2016
The Comparative Effects of Valsartan and Amlodipine on Vascular Microinflammation in Newly Diagnosed Hypertensive Patients
2012
Oxidative stress in chronic kidney disease
2018 Standout
Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease
2018
Magnesium in CKD: more than a calcification inhibitor?
2014
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Normal and Pathologic Concentrations of Uremic Toxins
2012 Standout
Oxidative stress and atherosclerosis in early chronic kidney disease
2006
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
2013 Standout
Differential Significance of Plasma Visfatin Concentrations according to Adiposity in Children and Adolescents
2013 Standout
Human Leptin Deficiency Caused by a Missense Mutation: Multiple Endocrine Defects, Decreased Sympathetic Tone, and Immune System Dysfunction Indicate New Targets for Leptin Action, Greater Central than Peripheral Resistance to the Effects of Leptin, and Spontaneous Correction of Leptin-Mediated Defects
1999
Sex differences in immune responses
2016 Standout
Managing the Risks of Prostate Disease During Testosterone Replacement Therapy in Older Men: Recommendations for a Standardized Monitoring Plan
2003
Serum Magnesium and Mortality in Hemodialysis Patients in the United States: A Cohort Study
2015
Flow-mediated vasodilatation of the brachial artery in children with chronic kidney disease
2008
Plasma concentration of visfatin is a new surrogate marker of systemic inflammation in type 2 diabetic patients
2010
The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease
2010
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
Estimated Glomerular Filtration Rate Is a Poor Predictor of Concentration for a Broad Range of Uremic Toxins
2011
Regional Anesthesia for Vascular Access Surgery
2009
Oxidative stress in patients with cardiovascular disease and chronic renal failure
2013
Chronic Kidney Disease
2016 Standout
Therapeutics targeting persistent inflammation in chronic kidney disease
2015
Adipose Tissue as an Endocrine Organ
2004 Standout
Hypomagnesemia and the Risk of Death and GFR Decline in Chronic Kidney Disease
2013
Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
2011 Standout
Oxidant Mechanisms in Renal Injury and Disease
2016
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
2006 Standout
Weight Reduction Increases Plasma Levels of an Adipose-Derived Anti-Inflammatory Protein, Adiponectin
2001 Standout
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Magnesium in Man: Implications for Health and Disease
2014 Standout
Graduated compression stockings for prevention of deep vein thrombosis
2014
The Tumor Lysis Syndrome
2011 Standout
Pyrolytic Depolymerization of Polyolefins Catalysed by Zirconium‐based UiO‐66 Metal–Organic Frameworks
2024 StandoutNobel
Pyrolysis Study of Polypropylene and Polyethylene Into Premium Oil Products
2014
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Lanthanum Chloride Inhibits LPS Mediated Expressions of Pro-Inflammatory Cytokines and Adhesion Molecules in HUVECs: Involvement of NF-κB-Jmjd3 Signaling
2017 Standout
Effect of CPAP on New Endothelial Dysfunction Marker, Endocan, in People With Obstructive Sleep Apnea
2015
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease
2011
Petrochemical feedstock by thermal cracking of plastic waste
2007
Gonadotropin treatment restoresin vitrointerleukin-1β and tumour necrosis factor-α production by stimulated peripheral blood mononuclear cells from patients with idiopathic hypogonadotropic hypogonadism
2003
Diabetic Kidney Disease
2017 Standout
Degradation Rates of Plastics in the Environment
2020 Standout
A review on pyrolysis of plastic wastes
2016 Standout
Arterial disease in chronic kidney disease
2012
Estimating Glomerular Filtration Rate in Older People
2014
Improving Dialysis Access: Regional Anesthesia Improves Arteriovenous Fistula Prevalence
2010
Serum Endocan Level and the Severity of Coronary Artery Disease
2014
Mechanisms of Diabetic Complications
2013 Standout
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Chronic Kidney Disease
2007
Guidelines for Perioperative Care in Elective Rectal/Pelvic Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations
2012 Standout
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
2020 Standout
Predictors of Lower Pole Renal Stone Clearance After Extracorporeal Shock Wave Lithotripsy
2002
The Metabolic Syndrome: Time for a Critical Appraisal
2005 Standout
Endocan, Novel Potential Biomarker for Systemic Sclerosis: Results of a Pilot Study
2015
The Vascular Endothelium and Human Diseases
2013 Standout
Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area.
1997
Understanding the Structure–Activity Relationships in Catalytic Conversion of Polyolefin Plastics by Zeolite-Based Catalysts: A Critical Review
2022
Works of Mutlu Sağlam being referenced
Endogenous Testosterone, Endothelial Dysfunction, and Cardiovascular Events in Men with Nondialysis Chronic Kidney Disease
2011
The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease
2015
Effects of Gonadotropin and Testosterone Treatments on Plasma Leptin Levels in Male Patients with Idiopathic Hypogonadotropic Hypogonadism and Klinefelter's Syndrome
1998
Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes
2011
Does preemptive stellate ganglion blockage increase the patency of radiocephalic arteriovenous fistula?
2006
The Relationship between Hemoglobin Levels and Endothelial Functions in Diabetes Mellitus
2009
Effect of renin–angiotensin–aldosterone system (RAAS) blockade on visfatin levels in diabetic nephropathy
2009
ADMA Levels Correlate with Proteinuria, Secondary Amyloidosis, and Endothelial Dysfunction
2008
Serum visfatin concentration and endothelial dysfunction in chronic kidney disease
2007
Serum Uric Acid Level and Endothelial Dysfunction in Patients with Nondiabetic Chronic Kidney Disease
2011
Effect of Lower Infundibulopelvic Angle, Lower Infundibulum Diameter and Inferior Calyceal Length on Stone Formation
1999
Relationship between Serum Magnesium Levels and Cardiovascular Events in Chronic Kidney Disease Patients
2012
Soluble TWEAK and PTX3 in Nondialysis CKD Patients
2011
Soluble TWEAK Plasma Levels as a Novel Biomarker of Endothelial Function in Patients with Chronic Kidney Disease
2009
Reduced proteinuria using ramipril in diabetic CKD stage 1 decreases circulating cell death receptor activators concurrently with ADMA. A novel pathophysiological pathway?
2010
The Relationship between IL-10 Levels and Cardiovascular Events in Patients with CKD
2014
Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin
2008
Normalization of endothelial dysfunction following renal transplantation is accompanied by a reduction of circulating visfatin/NAMPT. A novel marker of endothelial damage?
2009
FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease
2010
Hemoglobin is inversely related to flow-mediated dilatation in chronic kidney disease
2009
Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease
2014
Improving Proteinuria, Endothelial Functions and Asymmetric Dimethylarginine Levels in Chronic Kidney Disease: Ramipril versus Valsartan
2007
Novel Links between the Long Pentraxin 3, Endothelial Dysfunction, and Albuminuria in Early and Advanced Chronic Kidney Disease
2008
Effect of Renin Angiotensin System Blockade on Pentraxin 3 Levels in Type-2 Diabetic Patients With Proteinuria
2009
The Determinants of Endothelial Dysfunction in CKD: Oxidative Stress and Asymmetric Dimethylarginine
2005
Short-Term Treatment with Sevelamer Increases Serum Fetuin-A Concentration and Improves Endothelial Dysfunction in Chronic Kidney Disease Stage 4 Patients
2007
Combined Therapy with Renin-Angiotensin System and Calcium Channel Blockers in Type 2 Diabetic Hypertensive Patients with Proteinuria
2010
Naphtha derived from polyolefins
2004
Effects of Gonadotropin and Testosterone Treatments on Prostate Volume and Serum Prostate Specific Antigen Levels in Male Hypogonadism.
1997
A randomised clinical trial comparing the patient comfort and efficacy of three different graduated compression stockings in the prevention of postoperative deep vein thrombosis
2015